February 2012
Autonomic Technologies Initiates European Study of Novel Neurostimulator for the Treatment of Severe Migraine.

October 2011
Autonomic Technologies Announces Series C Financing.

July 2011
Medical Device Daily: New device may offer hope for 'suicide headache'. A Medical Device Daily Interview with ATI's Management.

June 2011
Autonomic Technologies Announces Positive Preliminary Findings For A Novel Device for the Treatment of Severe Headache.

March 2011
San Francisco Business Times Interviews ATI Board Member Kevin Wasserstein.

December 2010
ATI Announces First Patient Implant in European Cluster Headache Study.

November 2010
Mary Bellack joins ATI as Executive Vice President of Strategic Marketing, Regulatory and Quality.

June 2010
MD+DI (Medical Device and Diagnostic Industry) names ATI one of its top 50 companies to watch.